These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 12143263
21. [Pseudomyxoma peritonei--diagnosis and treatment]. Kanemitsu Y, Kato T, Hirai T. Gan To Kagaku Ryoho; 2003 May; 30(5):614-8. PubMed ID: 12795091 [Abstract] [Full Text] [Related]
22. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis]. Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M. Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661 [Abstract] [Full Text] [Related]
23. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Dis Colon Rectum; 2011 Mar; 54(3):293-9. PubMed ID: 21304299 [Abstract] [Full Text] [Related]
24. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O, Association Française de Chirurgie. Eur J Surg Oncol; 2010 May; 36(5):456-62. PubMed ID: 20227231 [Abstract] [Full Text] [Related]
25. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Andréasson H, Graf W, Nygren P, Glimelius B, Mahteme H. Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859 [Abstract] [Full Text] [Related]
26. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Saxena A, Yan TD, Chua TC, Morris DL. Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212 [Abstract] [Full Text] [Related]
27. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion. De Simone M, Vaira M, Caponi A, Ciaccio B, Fiorentini G, Turrisi G, Ferri L, Buti G. In Vivo; 2006 May; 20(6A):725-7. PubMed ID: 17203755 [Abstract] [Full Text] [Related]
35. [Pseudomyxoma peritonei]. Andreassen G. Tidsskr Nor Laegeforen; 1995 Sep 20; 115(22):2783. PubMed ID: 7570495 [Abstract] [Full Text] [Related]
36. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Järvinen P, Järvinen HJ, Lepistö A. Colorectal Dis; 2010 Sep 20; 12(9):868-72. PubMed ID: 19519686 [Abstract] [Full Text] [Related]
37. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ. Dis Colon Rectum; 2013 Dec 20; 56(12):1366-72. PubMed ID: 24201390 [Abstract] [Full Text] [Related]